
About
Mark Meiselbach is an Assistant Professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. He applies health economics methods to study privately managed insurance markets, including employer-sponsored insurance, Medicaid managed care, and Medicare Advantage, with a focus on access to mental health and substance use disorder treatments.
- PhD in Health Economics and Policy, Johns Hopkins Bloomberg School of Public Health (2022)
- BS in Quantitative Economics and Biology, Tufts University (2015)
Dr. Meiselbach's research investigates how policy and market forces shape insurer and employer decisions in health insurance markets and how these decisions affect enrollee access, affordability, and health outcomes. His work spans labor economics, insurance design, market power, and behavioral health. He frequently publishes in leading journals such as Health Affairs, Journal of Health Economics, and Medical Care Research and Review.
His recent publications reveal trends in hospital pricing disparities between commercial and Medicare Advantage plans, the impact of labor market concentration on insurance premiums, and how state policies affect access to buprenorphine prescribers in Medicaid. He has also analyzed high-deductible health plans’ effects on substance use outcomes and insurer market power in Medicaid managed care.
Scientific awards include:
- Best abstract in Health, Labor Markets, and the Economy, American Society of Health Economists Conference (2023)
- Best Abstract of the Health Economics Interest Group, AcademyHealth Annual Research Meeting (2022)
- Alan Gittelsohn Doctoral Scholarship, Johns Hopkins University (2021)
Dr. Meiselbach teaches Intermediate Health Economics at the Bloomberg School and is affiliated with the Hopkins Business of Health Initiative. He has advised or collaborated on numerous research projects related to healthcare affordability, market structure, and behavioral health access. His research has been widely covered in media and policy discussions, indicating strong public and academic impact. He maintains active research collaborations with scholars at Johns Hopkins and beyond, particularly in health services research and policy evaluation.
He leads and contributes to research examining provider networks, price transparency, and the financial implications of insurance design. His lab and research team focus on empirical health economics using large-scale claims and administrative data.




